GB2566235A - A novel formulation for rapid wound healing and control of infection - Google Patents

A novel formulation for rapid wound healing and control of infection

Info

Publication number
GB2566235A
GB2566235A GB1900381.3A GB201900381A GB2566235A GB 2566235 A GB2566235 A GB 2566235A GB 201900381 A GB201900381 A GB 201900381A GB 2566235 A GB2566235 A GB 2566235A
Authority
GB
United Kingdom
Prior art keywords
infection
wound healing
control
components
rapid wound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB1900381.3A
Other versions
GB2566235B (en
GB201900381D0 (en
Inventor
Choudhari Milind
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Welnnovate Biosolutions Pvt Ltd
Original Assignee
Welnnovate Biosolutions Pvt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Welnnovate Biosolutions Pvt Ltd filed Critical Welnnovate Biosolutions Pvt Ltd
Publication of GB201900381D0 publication Critical patent/GB201900381D0/en
Publication of GB2566235A publication Critical patent/GB2566235A/en
Application granted granted Critical
Publication of GB2566235B publication Critical patent/GB2566235B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/38—Silver; Compounds thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The present invention is a formulation of organic and non‐organic components for rapid wound healing and control of infection. The components of the present invention i.e. the formulation are an antimicrobial agent, an antioxidant, a cell proliferation inducing factor and an organic component responsible for matrix formation. Adding these four components in pre-determined proportions, formulations can be made for gels, liquid solution and biodegradable scaffolds which are safe and gives a synergistic effect.
GB1900381.3A 2016-07-22 2017-07-22 A novel formulation for rapid wound healing and control of infection Expired - Fee Related GB2566235B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN201621025112 2016-07-22
PCT/IN2017/050301 WO2018015976A1 (en) 2016-07-22 2017-07-22 A novel formulation for rapid wound healing and control of infection

Publications (3)

Publication Number Publication Date
GB201900381D0 GB201900381D0 (en) 2019-02-27
GB2566235A true GB2566235A (en) 2019-03-06
GB2566235B GB2566235B (en) 2022-02-16

Family

ID=60992252

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1900381.3A Expired - Fee Related GB2566235B (en) 2016-07-22 2017-07-22 A novel formulation for rapid wound healing and control of infection

Country Status (2)

Country Link
GB (1) GB2566235B (en)
WO (1) WO2018015976A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019152766A1 (en) * 2018-02-01 2019-08-08 North Carolina State University Antimicrobial platelet-like particles
CN111588837B (en) * 2020-05-14 2023-06-06 中南大学湘雅三医院 Preparation method of protein-nano silver compound, prepared compound and application
CN116327684B (en) * 2023-03-20 2024-06-11 南京农业大学 Halofuginone-silver nano thermosensitive gel and preparation method and application thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7678393B1 (en) * 2006-04-23 2010-03-16 DB Laboratories LLC Mixture composition and method useful for topical and internal application
WO2014147638A1 (en) * 2013-03-22 2014-09-25 Datt Mediproducts Limited A multifunctional natural wound healing matrix

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2218447B1 (en) * 2008-11-04 2017-04-19 PharmaSol GmbH Compositions containing lipid micro- or nanoparticles for the enhancement of the dermal action of solid particles

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7678393B1 (en) * 2006-04-23 2010-03-16 DB Laboratories LLC Mixture composition and method useful for topical and internal application
WO2014147638A1 (en) * 2013-03-22 2014-09-25 Datt Mediproducts Limited A multifunctional natural wound healing matrix

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
- THIRUMURUGAN GUNASEKARAN et al., "Silver nanoparticles as real topical bullets for wound healing", Journal of the American College of Clinical Wound Specialists, (20120000), vol. 3, pages 82 - 96 *
HSINYU LEE, EDWARD J. GOETZL, SONGZHU AN: "Lysophosphatidic acid and sphingosine 1-phosphate stimulate endothelial cell wound healing", AMERICAN JOURNAL OF PHYSIOLOGY. CELL PHYSIOLOGY., AMERICAN PHYSIOLOGICAL SOCIETY., US, vol. 278, no. 3, 1 March 2000 (2000-03-01), US, pages C612 - C618, XP055455290, ISSN: 0363-6143, DOI: 10.1152/ajpcell.2000.278.3.C612 *

Also Published As

Publication number Publication date
WO2018015976A1 (en) 2018-01-25
GB2566235B (en) 2022-02-16
GB201900381D0 (en) 2019-02-27

Similar Documents

Publication Publication Date Title
GT201700192A (en) COMBINATIONS OF ACTIVE COMPOUNDS FROM THE FUNGICIDE VIEWPOINT
CL2017002650A1 (en) Novel compounds
MX2018012486A (en) Compositions for topical application of compounds.
CL2016002027A1 (en) Cyclopropylamine as an inhibitor of lsd1
BR112018010720A8 (en) apelin receptor agonists and methods of use
SV2017005461A (en) BENZAMIDS REPLACED WITH 1,3-TIAZOL-2-ILO
CL2015001864A1 (en) Compounds derived from substituted spiropyrido [1,2-a] pyrazine, as hiv integrase inhibitors; pharmaceutical composition that includes them; and its use for the prophylaxis or treatment of a hiv infection.
NI201900051A (en) MAGL INHIBITORS
AU2016278853A8 (en) Petrolatum-based compositions comprising cationic biocides
CL2016000807A1 (en) Amino heteroaryl benzamides as kinase inhibitors.
CL2016001231A1 (en) Autotaxin Inhibitor Compounds
ECSP19035377A (en) MAGL INHIBITORS
CL2019003398A1 (en) Pyrazole magl inhibitors.
CL2017002482A1 (en) Heterocyclic compounds and their use in the prevention or treatment of bacterial infections
BR112018008601A2 (en) compositions comprising cannabidiol and second therapeutic agents for the treatment of cancer
MX2015014898A (en) Antimicrobial compositions and methods of making the same.
CL2019003397A1 (en) Pyrazole magl inhibitors.
CL2017001025A1 (en) Compounds for use in anthelmintic treatment
CL2017002451A1 (en) Novel heterocyclic compounds and their use in the prevention or treatment of bacterial infections
BR112022002289A2 (en) Liquid dressing compositions and their veterinary uses
GB2566235A (en) A novel formulation for rapid wound healing and control of infection
CL2017002803A1 (en) Heterocyclic compounds and their use in the prevention or treatment of bacterial infections
CL2016001104A1 (en) Pharmaceutical preparation and method of its production and use.
BR112016016901A2 (en) agents for use in the treatment of retinal inflammation
PE20150755A1 (en) TRANSDERMAL FORMULATION CONTAINING COX INHIBITORS

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20220516